Biomarkers: Polycystic ovary syndrome: steroid assessment for diagnosis

Simple item page
dc.contributor.authorHickey, T.
dc.contributor.authorNorman, R.
dc.date.issued2010
dc.description.abstractHyperandrogenism is the key pathologic feature of polycystic ovary syndrome, but diagnostic assessment of androgen excess in women is problematic, and the biochemical assays in routine clinical practice are largely considered uninformative. is it time to add new diagnostic modalities to the clinical toolbox and perhaps measure levels of estrogen instead?
dc.description.statementofresponsibilityTheresa E. Hickey and Robert J. Norman
dc.identifier.citationNature Reviews Endocrinology, 2010; 6(6):305-307
dc.identifier.doi10.1038/nrendo.2010.68
dc.identifier.issn1759-5029
dc.identifier.issn1759-5037
dc.identifier.orcidHickey, T. [0000-0002-2752-730X]
dc.identifier.orcidNorman, R. [0000-0002-3118-3896]
dc.identifier.urihttp://hdl.handle.net/2440/65095
dc.language.isoen
dc.publisherNature Publishing Group
dc.rights© 2010 Macmillan Publishers Limited. All rights reserved
dc.source.urihttps://doi.org/10.1038/nrendo.2010.68
dc.subjectHumans
dc.subjectPolycystic Ovary Syndrome
dc.subjectAndrogens
dc.subjectEstrogens
dc.subjectFemale
dc.subjectBiomarkers
dc.titleBiomarkers: Polycystic ovary syndrome: steroid assessment for diagnosis
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Obstetrics and Gynaecology publications